| 摘要 |
<p>Disclosed is treatment of ocular hypertension and glaucoma by long term therapy with a prostaglandin related compound for eliminating or reducing potential iridic pigmentation. Composition useful for the treatment, and use of the prostaglandin related compound for producing the composition are also disclosed.</p> |
